CSIMarket
Company Name or Ticker Symbol
Search for other Categories


Gilead Sciences Inc  (GILD)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare


 

Gilead Sciences Inc

GILD's Financial Statements and Analysis



Gilead Sciences Inc reported in IV. Quarter net earnings per share of $0.00 an improvement compare to net loss per share of $-2.93 recorded a year ago and decline of -99.86 % from $1.60 earned in III. Quarter (Sep 30 2018).


IV. Quarter
Earnings Per Share Revenues
$ 0 $  5,795 Mill
$+2.93     $-154M     -2.59 %



Gilead Sciences Inc's Revenue fell by -2.59 % in IV. Quarter (Dec 31 2018) year on year, to $5,795 million and advanced by 3.56 % sequentially.


Gilead Sciences Inc is Expected to report next financial results on April 29, 2019.

More on GILD's Income Statement





       
  • Viread 3.94% Y/Y,
• Truvada 5.26% Y/Y,
• Emtriva 22.55% Y/Y,
• HIV products Total 18.47% Y/Y,
• AmBisome 8.66% Y/Y,
• Other products 461.95% Y/Y,
• Letairis 21.62% Y/Y,
• Ranexa 15.62% Y/Y,
• Complera Eviplera 22.55% Y/Y,
• Stribild 65.85% Y/Y
   
     
       
  • Atripla -10.19% Y/Y,
• Sovaldi -62.91% Y/Y
   
     


GILD's Segments

Gilead Sciences Inc's net income of $3 million in IV. Quarter increased from net loss of $-3,836 million IV. Quarter a year ago.

Sequentially net earnings fell by -99.86 % from net income of $2,099.00 million realized in previous quarter.

More on GILD's Growth

Inventories grew by 1.62 % to $814 million from IV. Quarter a year ago, sequentially inventories fell by -0.25 %. GILD's Cash flow In IV. Quarter company's net cash flow was $3,371 million, capital expenditures fell by 12.73%, to $-248 millions compare to same quarter a year ago and fell by 48.50% from III. Quarter (Sep 30 2018).

More on GILD's Cash flow Statement


Gilead Sciences Inc payed out dividend of $2.28 per share in last 52 weeks representing 54.81 % of net earning per share in trailing twelve-month period.

During the same period Gilead Sciences Inc earned $ 6.48 cash per share, on a free-cash flow basis 155.68 % of net earning per share.

Book value fell by -5.68 % sequentially to $16.60 per share.
Tangible Book value fell to $ 1.29 per share from $ 1.97.

Company repurchased 10.00 million shares or 0.77 % in IV. Quarter.
Interest Coverage Ratio was 8.24. Debt Coverage Ratio was 0.31.

More on GILD's Dividends

 Market Capitalization (Millions) 81,646
 Shares Outstanding (Millions) 1,297
 Total Debt (Millions $) 27,322
 Revenue (TTM) (Millions $) 22,127
 Net Income (TTM) (Millions $) 5,460
 Cash Flow (TTM) (Millions $) 10,352
 Capital Exp. (TTM) (Millions $) -924
 Dividend TTM ($) 2.28 $
 Dividend Yield TTM (%) 3.61 %
 Employees (TTM) $ 7,000




Gilead Sciences Inc payed out dividend of $2.28 per share in last 52 weeks representing 54.81 % of net earning per share in trailing twelve-month period.

During the same period Gilead Sciences Inc earned $ 6.48 cash per share, on a free-cash flow basis 155.68 % of net earning per share.

Book value fell by -5.68 % sequentially to $16.60 per share.
Tangible Book value fell to $ 1.29 per share from $ 1.97.

Company repurchased 10.00 million shares or 0.77 % in IV. Quarter.
Interest Coverage Ratio was 8.24. Debt Coverage Ratio was 0.31.

More on GILD's Balance Sheets

 Market Capitalization (Millions) 81,646
 Shares Outstanding (Millions) 1,297
 Total Debt (Millions $) 27,322
 Revenue (TTM) (Millions $) 22,127
 Net Income (TTM) (Millions $) 5,460
 Cash Flow (TTM) (Millions $) 10,352
 Capital Exp. (TTM) (Millions $) -924
 Dividend TTM ($) 2.28 $
 Dividend Yield TTM (%) 3.61 %
 Employees (TTM) $ 7,000


   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

XTNT's Profile

Stock Price

XTNT's Financials

Business Description

Fundamentals

Charts & Quotes

XTNT's News

Suppliers

XTNT's Competitors

Customers & Markets

Economic Indicators

XTNT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071